Ling-mei Wang
Vice President
Oncology
CHO Pharma
Taiwan
Biography
Dr. Ling-Mei Wang received her Ph.D. degree from University of Texas Health Science Center at San Antonio, USA. Dr. Wang has over 25 years of experience in management and in a wide spectrum of research area including cancer, genomics and regenerative medicine. Prior to joining CHO Pharma, she was the Chief Operating Officer of Supra Integration and Incubation Center (Si2C), the Deputy General Director and the Chief Technology Officer at Biomedical Technology and Device Research Laboratories of Industrial Technology Research Institute (ITRI), and Director of R&D at Vita Genomics. During her time in USA, Dr. Wang worked at the National Cancer Institute and Van Andel Research Institute on cancer research.
Research Interest
Cancer, genomics and regenerative medicine
